ArticleFrontiers in oncology2021

Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma.

Ruimin Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.